"Das St. Josefs-Hospital ist ein Akutkrankenhaus der Schwerpunktversorgung in der hessischen Landeshauptstadt Wiesbaden. Bekannt ist es als das "JoHo". Gegründet wurde das JoHo Wiesbaden am 25. November 1876 und verfügt heute über 17 medizinische Fachabteilungen mit rund 500 Betten. Alleiniger Anteilseigner ist die St. Josefs-Hospital Wiesbaden Stiftung. Fachabteilungen: Allgemein- Viszeralchirurgie, Anästhesie, Gynäkologie und Geburtshilfe, Gefäßmedizin, Herzchirurgie, HNO Belegabteilung, Interdisziplinäre Intensivmedizin, Koloproktologie, Medizinische Kliniken: Kardiologie, Gastroenterologie, Palliativmedizin und Onkologie, Neurologie, Notfallmedizin, Orthopädie, Radiologie, Unfallchirurgie, Wirbelsäulenzentrum"

During the past decade, St. Josefs-Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 2 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Josefs-Hospital" #1 sponsor was "St. Josefs-Hospital Wiesbaden GmbH" with 5 trials, followed by "University of Leipzig" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "AGO Study Group" with 1 trials sponsored and "AIO-Studien-gGmbH" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Josefs-Hospital" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "St. Josefs-Hospital" are "Atrial Fibrillation" (3 trials), "Breast Cancer" (3 trials), "Primary Biliary Cholangitis" (3 trials), "Ovarian Cancer" (2 trials) and "PBC" (2 trials). Many other conditions were trialed in "St. Josefs-Hospital" in a lesser frequency.

Most popular intervention types in "St. Josefs-Hospital" are "Drug" (14 trials), "Procedure" (4 trials), "Device" (3 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Bevacizumab" (3 trials), "Carboplatin" (2 trials), "Abagovomab" (1 trials) and "Abemaciclib + Aromatase Inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Josefs-Hospital" are 17 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "St. Josefs-Hospital". undefined are not yet recruiting, 11 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in St. Josefs-Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Josefs-Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".